Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Quattro74on May 19, 2020 10:46am

133 Views

Post# 31045831

RE:RE:RE:RE:News

The Final Hurdle guys, we've cleared it. Should be a sprint from here. It wont be long Laser b4 we're at your $2. ;-)

LaserStock29 wrote: Seems the REBs are needed for US sites. Is that for just the newly onboarded or all thus far. Knowing tlt its probably all. Would be nice to get a clarification We should get full phase 1 credit valuation wise now. I wont celebrate till we surpass .60

skier59 wrote: Yup finally great news Laser, hopefully it will give our SP some Fast Track acceleration ! Glad to see both Fast-Track and Break Through Status is on the table and agreed should we demonstrate similar results in the Phase2 as we had in the Phase1b.